Skip to main content
OpenTrials
Completed

NCT Number: NCT05963802

Evaluation of the Efficacy and Usability of Artificial Intelligence (ChatGPT) for Health Sciences Students

Crossover Randomized Control trial, in which subjects are randomly assigned to one of two groups: one (ChatGPT) receiving the intervention that is being tested, and the control group receiving usual online resources.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Carleton University

Ottawa, Canada

About this study

A two-stage randomization strategy will be adopted. The allocation of participants into event groups A and B will be determined through computer-generated randomization in an allocation ratio: 1:1. To address ethical concerns regarding power dynamics between professors and students; the investigators have opted to involve an individual who is independent of the research team. This decision aims to minimize any potential bias or influence that could arise from direct professor involvement in the intervention. This approach helps ensure that the study is conducted fairly and unbiasedly, fostering a research environment that prioritizes equal opportunities for all participants. Both groups will simultaneously work on an assignment (A and B).

The investigators employed a cross-over design to ensure equity in the learning experience for all students. This involved assigning students either the ChatGPD (A) or the regular online tools (B) for accessing resources and assisting them with their assignments. During the initial phase of the intervention, participants in group A will utilize ChatGPT to complete their assignments, while participants in Group B will serve as the control group. In the subsequent period, the interventions will switch between the two groups. To assess the participants' technology usability, both groups will complete pre-and post-questionnaires. Additionally, participants will be requested to fill out a post-intervention questionnaire to evaluate their perceptions of the assistance methods. After a period of a wash-out of 13 days/week, participants who were previously allocated to Group A will be allocated to Group B and the same with participants previously allocated to Group B will be to Group A. This crossover randomized control trial will include 50 health sciences students who are registered to the course Chronic Health Conditions and Disability ( HLTH 3503), Carleton University. During the first part of the intervention, A group will use ChatGPT to complete their assignment, while B participants will act as a control group. In the second week, the interventions will cross over. Both groups' participants will complete a pre-and post-questionnaire to assess their knowledge. Participants will also complete a post-intervention questionnaire to evaluate their perceptions. The System Usability Scale (SUS) will be administered at the end of the interventions and when participants cross over to the other assistance tool. This allows for the assessment of outcomes and comparisons within and between the two intervention arms. By collecting data at multiple points in the study, the investigators can evaluate the effects of each intervention and any potential carryover effects during the crossover period. Additionally, it provides an opportunity to measure changes in outcomes within individual participants as they switch from one intervention to another. The questionnaire about socioeconomic, literacy questions, Benefits of AI and risks and negative experiences associated with AI usage.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Health Science students
  • Must be registered for the course Chronic Health Conditions and Disability (HLTH 3503), Fall 2023.

Exclusion criteria

  • Unable to provide informed consent

Treatment and study plan

Artificial Intelligence (ChatGPT) Group

Other

Participants in Group A will be assigned to utilize ChatGPT as their tool to complete assignments. They will be given a period of six days to utilize artificial intelligence through ChatGPT for assignment completion. Along with the assignment instructions, participants will receive an ethical guideline and specific guidelines on how to effectively utilize ChatGPT. Once the intervention period is concluded, participants will be given a 24-hour window to complete a survey that assesses the usability of the technology. The survey aims to gather valuable feedback on the participants' experience and perception of using ChatGPT for their assignments. In addition, participants in Arm 1 will also be asked to fill out a survey regarding their perception of using artificial intelligence (AI) as an assistance tool to complete their assignments. This survey aims to gather insights into their thoughts, opinions, and attitudes towards utilizing AI in the learning process.

Primary outcomes

  1. System Usability Scale (SUS) scores are 0-100,The average SUS score is 68.

    Time frame: within 24 hours

    Technology usability

Secondary outcomes

  1. Student's perception of artificial intelligence, questionnaire reviwed by experts, No recognised gold standard measurement for outcome.

    Time frame: within 24 hours

    Student's perception about the use of artificial intelligence

Sponsors and collaborators

Lead sponsor

Carleton University

Other

Collaborators

  • Université de Montréal

Registry information

Official study title

Crossover Randomized Controlled Trial to Evaluate the Efficacy and Usability of Artificial Intelligence (ChatGPT) for Health Sciences Students (AIHSS)

Acronym: AIHSS

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jul 27, 2023
Registry last updated
Feb 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.